# Tag: Fleury

- [Listed Healthcare Companies Create Nearly 80,000 Jobs, Expanding Headcount by 48% Since 2019](https://brazilstockguide.com/insights/listed-healthcare-companies-create-nearly-80000-jobs-expanding-headcount-by-48-since-2019/) (2026-06-29): A BTG Pactual survey shows ten listed healthcare companies increased their combined workforce from about 166,000 to 245,000 employees; Hapvida and Rede D’Or led the expansion.
- [Oncoclinicas Delays 2025 Results; Next 15 Days Will Be Decisive](https://brazilstockguide.com/insights/oncoclinicas-delays-2025-results/) (2026-03-30): Company seeks waiver to avoid technical default while negotiating restructuring with Porto and Fleury under liquidity pressure.
- [Mak Capital Slams Fleury–Porto Rescue Plan for Oncoclínicas](https://brazilstockguide.com/insights/oncoclinicas-rescue-fleury-porto-mak-capital/) (2026-03-24): Shareholder says proposed NewCo is too complex and fails to address urgent liquidity needs.
- [Update: Fleury Joins Porto in Oncoclinicas Push, Forces Founder Exit](https://brazilstockguide.com/insights/fleury-porto-oncoclinicas-deal/) (2026-03-23): Non-binding deal outlines NewCo structure with R$2.5 billion in liabilities as creditors prepare to vote.
- [Fleury profit rises to R$96.3 million in 4Q25 as diagnostics demand grows](https://brazilstockguide.com/insights/fleury-4q25-results-profit/) (2026-03-05): Revenue climbs 12% year-on-year while EBITDA reaches R$455.9 million, supported by B2C expansion and acquisitions.
- [Fleury defends disciplined M&amp;A cycle, says expansion to stay ‘measured and strategic’](https://brazilstockguide.com/insights/leury-3q25-qanda-mna-discipline/) (2025-11-07): Executives highlight strong pipeline but reject overpaying as company balances growth with low leverage and cash generation.
- [Fleury show organic growth surge led by B2C segment](https://brazilstockguide.com/insights/fleury-results-3q25/) (2025-11-06): Diagnostic group gains market share as flagship brand and regional units drive expansion.
- [Fleury expands in São Paulo’s interior with LSL acquisition](https://brazilstockguide.com/insights/fleury-acquires-lsl-expands-inland-network/) (2025-10-28): Transaction strengthens regional network and requires no shareholder vote.
- [Rede D’Or says talks with Fleury stalled; denies negotiations with Dasa and Aliança](https://brazilstockguide.com/insights/rede-dor-denies-talks-with-dasa-alianca-fleury-stalled/) (2025-10-21): Company responds to regulator after report on potential acquisitions
- [Fleury admits talks with Rede D’Or, denies suspension of negotiations](https://brazilstockguide.com/insights/fleury-rede-dor-negotiations/) (2025-10-20): After a report suggested a halt in discussions, Fleury confirms ongoing talks with Rede D’Or but says no decision or binding agreement has been made.
- [Medical Fever](https://brazilstockguide.com/behind-the-lines/medical-fever/) (2025-09-02): In the post-pandemic era, healthcare consolidation is back in fashion. Brazil may swap hundreds of operators for just four big groups.
